Cytokeratin (CK)-positive bone marrow micrometastases (BMM) and survival in stage I-III breast cancer

被引：0
|
作者：
Braun, S
Pantel, K
Janni, W
Hepp, F
Kentenich, CRM
Müller, P
Gastroph, S
机构：
[1] LMU Munchen, Frauenklin, Munich, Germany
[2] UKE, Frauenklin, Hamburg, Germany
[3] KZVA, Med Klin 2, Augsburg, Germany
[4] LMU, Inst Immunol, Munich, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80708-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] Survival and ERB-B2 expression of cytokeratin-18 (CK18) bone marrow micrometastases (BMM) in stage I-III breast cancer
    Braun, S
    Schlimok, G
    Schaller, G
    Heumos, IJ
    Pantel, K
    Frauenklinik, I
    Munchen, LMU
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S189 - S189
  • [2] Clinical value of screening for cytokeratin (CK)-positive bone marrow micrometastases in stage I-II cervical cancer
    Hepp, F
    Kentenich, CRM
    Janni, W
    Braun, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S230 - S230
  • [3] Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    Braun, S
    Pantel, K
    Muller, P
    Janni, W
    Hepp, F
    Kentenich, CRM
    Gastroph, S
    Wischnik, A
    Dimpfl, T
    Kindermann, G
    Riethmuller, G
    Schlimok, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08): : 525 - 533
  • [4] Clinical value of bone marrow micrometastases (BMM) in recurrent breast cancer patients
    Janni, W
    Hepp, F
    Kentenich, CRM
    Sommer, HL
    Braun, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S321 - S321
  • [5] Prognostic value of cytokeratin (CK)-positive bone marrow micrometastsaes (BMM) detected in high-risk breast cancer patients after adjuvant chemotherapy
    Kentenich, CRM
    Janni, W
    Hepp, F
    de Waal, J
    Willgeroth, F
    Sommer, HL
    Braun, S
    Frauenklinik, I
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S159 - S159
  • [6] Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. (vol 342, pg 525, 2000)
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04): : 308 - +
  • [7] Correlation of Bone Marrow Micrometastases and Micrometastatic Lymph Node Deposits in Stage I-III Colon Cancer Patients: A Prospective Multicenter Study
    Weixler, B.
    Warschkow, R.
    Viehl, C. T.
    Guller, U.
    Zuber, M.
    Eberlein, T.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S75 - S76
  • [8] Incidence and survival among young women with stage I-III breast cancer
    Thomas, A.
    Rhoads, A.
    Pinkerton, E.
    Schroeder, M. C.
    Oelson, J. J.
    McNally, L. R.
    Hundley, W. G.
    Conway, K.
    Lynch, C. F.
    Romitti, P. A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Survival after recurrence of stage I-III breast, colorectal, or lung cancer
    Hassett, Michael J.
    Uno, Hajime
    Cronin, Angel M.
    Carroll, Nikki M.
    Hornbrook, Mark C.
    Fishman, Paul
    Ritzwoller, Debra P.
    CANCER EPIDEMIOLOGY, 2017, 49 : 186 - 194
  • [10] Effect of glucocorticoid use on survival in patients with stage I-III breast cancer
    Lin, Ching-Hung
    Chuang, Po-Ya
    You, San-Lin
    Chiang, Chun-Ju
    Huang, Chiun-Sheng
    Wang, Ming-Yang
    Chao, Ming
    Lu, Yen-Shen
    Cheng, Ann-Lii
    Tang, Chao-Hsiun
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 225 - 234
12345